Concepedia

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Paul E. Sax, David A. Wohl, Michael T. Yin, Frank A. Post, Edwin DeJesus, Michael S. Saag, Anton Pozniak, Melanie Thompson, Daniel Podzamczer, Jean‐Michel Molina,

The Lancet · 2015 · 598 citations · 24 references

References

24

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

Annals of Internal Medicine · 1998 · 5.2K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

Grace A. McComsey, Douglas Kitch, Eric S. Daar et al. · The Journal of Infectious Diseases · 2011 · 497 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +16

Association of tenofovir exposure with kidney disease risk in HIV infection

Rebecca Scherzer, Michelle M. Estrella, Yongmei Li et al. · AIDS · 2012 · 424 citations

Veterinary Medicine, Infectious Diseases, Nephrology +17

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

Hans‐Jürgen Stellbrink, Chloe Orkin, José Ramón Arribas et al. · Clinical Infectious Diseases · 2010 · 411 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

Amanda Mocroft, Ole Kirk, Peter Reiss et al. · AIDS · 2010 · 405 citations

Medicine, Nephrology, Pharmacotherapy +17